{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,4]],"date-time":"2026-11-04T21:21:40Z","timestamp":1793827300015,"version":"4.6.1"},"reference-count":62,"publisher":"BMJ","issue":"4","license":[{"start":{"date-parts":[[2024,4,30]],"date-time":"2024-04-30T00:00:00Z","timestamp":1714435200000},"content-version":"unspecified","delay-in-days":29,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100000265","name":"Medical Research Council","doi-asserted-by":"publisher","award":["T008768"],"award-info":[{"award-number":["T008768"]}],"id":[{"id":"10.13039\/501100000265","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100020171","name":"Foreign, Commonwealth and Development Office","doi-asserted-by":"publisher","award":["T008768"],"award-info":[{"award-number":["T008768"]}],"id":[{"id":"10.13039\/501100020171","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["bmj.com"],"crossmark-restriction":true},"short-container-title":["BMJ Glob Health"],"accepted":{"date-parts":[[2024,3,31]]},"published-print":{"date-parts":[[2024,4]]},"abstract":"<jats:p>In October 2021, the WHO recommended the world\u2019s first malaria vaccine\u2014RTS,S\/AS01\u2014to prevent malaria in children living in areas with moderate-to-high transmission in sub-Saharan Africa (SSA). A second malaria vaccine, R21\/Matrix-M, was recommended for use in October 2023 and added to the WHO list of prequalified vaccines in December 2023. This study analysis assessed the country status of implementation and delivery strategies for RTS,S\/AS01 by searching websites for national malaria policies, guidelines and related documents. Direct contact with individuals working in malaria programmes was made to obtain documents not publicly available. 10 countries had documents with information relating to malaria vaccine implementation, 7 referencing RTS,S\/AS01 and 3 (Burkina Faso, Kenya and Nigeria) referencing RTS,S\/AS01 and R21\/Matrix-M. Five other countries reported plans for malaria vaccine roll-out without specifying which vaccine. Ghana, Kenya and Malawi, which piloted RTS,S\/AS01, have now integrated the vaccine into routine immunisation services. Cameroon and Burkina Faso are the first countries outside the pilot countries to incorporate the vaccine into national immunisation services. Uganda plans a phased RTS,S\/AS01 introduction, while Guinea plans to first pilot RTS,S\/AS01 in five districts. The RTS,S\/AS01 schedule varied by country, with the first dose administered at 5 or 6 months in all countries but the fourth dose at either 18, 22 or 24 months. SSA countries have shown widespread interest in rolling out the malaria vaccine, the Global Alliance for Vaccines and Immunization having approved financial support for 20 of 30 countries which applied as of March 2024. Limited availability of RTS,S\/AS01 means that some approved countries will not receive the required doses. Vaccine availability and equity must be addressed even as R21\/Matrix-M becomes available.<\/jats:p>","DOI":"10.1136\/bmjgh-2023-014719","type":"journal-article","created":{"date-parts":[[2024,4,30]],"date-time":"2024-04-30T12:00:43Z","timestamp":1714478443000},"page":"e014719","update-policy":"https:\/\/doi.org\/10.1136\/crossmarkpolicy","source":"Crossref","is-referenced-by-count":57,"title":["Policy uptake and implementation of the RTS,S\/AS01 malaria vaccine in sub-Saharan African countries: status 2 years following the WHO recommendation"],"prefix":"10.1136","volume":"9","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-2867-6224","authenticated-orcid":false,"given":"Caroline Bonareri","family":"Osoro","sequence":"first","affiliation":[{"name":"Centre for Global Health Research, Kenya Medical Research Institute, Kisumu, Kenya"},{"name":"Department of Global Health, Stellenbosch University, Stellenbosch, South Africa"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eleanor","family":"Ochodo","sequence":"additional","affiliation":[{"name":"Centre for Global Health Research, Kenya Medical Research Institute, Kisumu, Kenya"},{"name":"Department of Global Health, Stellenbosch University, Stellenbosch, South Africa"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Titus K","family":"Kwambai","sequence":"additional","affiliation":[{"name":"Centers for Disease Control and Prevention, Kisumu, Kenya"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9521-624X","authenticated-orcid":false,"given":"Jenifer Akoth","family":"Otieno","sequence":"additional","affiliation":[{"name":"Centre for Global Health Research, Kenya Medical Research Institute, Kisumu, Kenya"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lisa","family":"Were","sequence":"additional","affiliation":[{"name":"Centre for Global Health Research, Kenya Medical Research Institute, Kisumu, Kenya"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7316-3340","authenticated-orcid":false,"given":"Caleb Kimutai","family":"Sagam","sequence":"additional","affiliation":[{"name":"Centre for Global Health Research, Kenya Medical Research Institute, Kisumu, Kenya"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eddy Johnson","family":"Owino","sequence":"additional","affiliation":[{"name":"Centre for Global Health Research, Kenya Medical Research Institute, Kisumu, Kenya"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Simon","family":"Kariuki","sequence":"additional","affiliation":[{"name":"Centre for Global Health Research, Kenya Medical Research Institute, Kisumu, Kenya"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Feiko O","family":"ter Kuile","sequence":"additional","affiliation":[{"name":"Department of Clinical Sciences, Liverpool School of Tropical Medicine, Liverpool, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1588-485X","authenticated-orcid":false,"given":"Jenny","family":"Hill","sequence":"additional","affiliation":[{"name":"Department of Clinical Sciences, Liverpool School of Tropical Medicine, Liverpool, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"239","published-online":{"date-parts":[[2024,4,30]]},"reference":[{"key":"2025072914520952000_9.4.e014719.1","doi-asserted-by":"crossref","DOI":"10.1186\/s40249-016-0151-8","article-title":"Malaria: global progress 2000 - 2015 and future challenges","volume":"5","author":"Cibulskis","year":"2016","journal-title":"Infect Dis Poverty"},{"key":"2025072914520952000_9.4.e014719.2","unstructured":"WHO . World malaria report 2023. Geneva: World Health Organization; 2023."},{"key":"2025072914520952000_9.4.e014719.3","unstructured":"WHO: World Malaria Report . World malaria report 2022. Geneva: WHO; 2022.293."},{"key":"2025072914520952000_9.4.e014719.4","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1172\/JCI156588","article-title":"RTS,S: the first malaria vaccine","volume":"132","author":"Zavala","year":"2022","journal-title":"J Clin Invest"},{"key":"2025072914520952000_9.4.e014719.5","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pmed.1001685","article-title":"Efficacy and safety of the RTS,S\/As01 malaria vaccine during 18 months after vaccination: a phase 3 randomized, controlled trial in children and young infants at 11 African sites","volume":"11","year":"2014","journal-title":"PLoS Med"},{"key":"2025072914520952000_9.4.e014719.6","unstructured":"WHO . WHO recommends groundbreaking malaria vaccine for children at risk [news release]. Geneva: World Health Organization; 2021."},{"key":"2025072914520952000_9.4.e014719.7","doi-asserted-by":"crossref","first-page":"897","DOI":"10.1016\/j.vaccine.2019.10.077","article-title":"Safety and Immunogenicity of the RTS,S\/As01 malaria vaccine in infants and children identified as HIV-infected during a randomized trial in sub-Saharan Africa","volume":"38","author":"Otieno","year":"2020","journal-title":"Vaccine"},{"key":"2025072914520952000_9.4.e014719.8","doi-asserted-by":"crossref","first-page":"1134","DOI":"10.1016\/S1473-3099(16)30161-X","article-title":"Safety and Immunogenicity of RTS,S\/As01 malaria vaccine in infants and children with WHO stage 1 or 2 HIV disease: a randomised, double-blind, controlled trial","volume":"16","author":"Otieno","year":"2016","journal-title":"Lancet Infect Dis"},{"key":"2025072914520952000_9.4.e014719.9","doi-asserted-by":"crossref","first-page":"1005","DOI":"10.1056\/NEJMoa2026330","article-title":"Seasonal malaria vaccination with or without seasonal malaria chemoprevention","volume":"385","author":"Chandramohan","year":"2021","journal-title":"N Engl J Med"},{"key":"2025072914520952000_9.4.e014719.10","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(15)60721-8"},{"key":"2025072914520952000_9.4.e014719.11","doi-asserted-by":"crossref","unstructured":"Wadman M . First malaria vaccine slashes early childhood mortality. in science. 2023. doi:10.1126\/science.adl5521","DOI":"10.1126\/science.adl5521"},{"key":"2025072914520952000_9.4.e014719.12","unstructured":"Hamel M . Update on malaria vaccines. Meeting of the Strategic Advisory Group of Experts on Immunization; Cameroon, 2024"},{"key":"2025072914520952000_9.4.e014719.13","doi-asserted-by":"crossref","first-page":"S48","DOI":"10.1038\/d41586-022-04343-7","article-title":"The slow roll-out of the world\u2019s first malaria vaccine","volume":"612","author":"Willyard","year":"2022","journal-title":"Nature"},{"key":"2025072914520952000_9.4.e014719.14","unstructured":"WHO . Malaria Vaccine: WHO Position Paper \u2013 March 2022. In Weekly Epidemiological Record, Vol. 2022; WHO; 2022.60\u201378."},{"key":"2025072914520952000_9.4.e014719.15","doi-asserted-by":"publisher","DOI":"10.4103\/1995-7645.374354"},{"key":"2025072914520952000_9.4.e014719.16","unstructured":"Organization WH . Malaria vaccine technology roadmap. Geneva: WHO; 2023.11."},{"key":"2025072914520952000_9.4.e014719.17","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(21)00943-0"},{"key":"2025072914520952000_9.4.e014719.18","doi-asserted-by":"crossref","first-page":"1728","DOI":"10.1016\/S1473-3099(22)00442-X","article-title":"Efficacy and Immunogenicity of R21\/matrix-M vaccine against clinical malaria after 2 years' follow-up in children in Burkina Faso: a phase 1\/2B randomised controlled trial","volume":"22","author":"Datoo","year":"2022","journal-title":"Lancet Infect Dis"},{"key":"2025072914520952000_9.4.e014719.19","unstructured":"WHO . WHO recommends R21\/matrix-M vaccine for malaria prevention in updated advice on immunization. Geneva. 2023.1."},{"key":"2025072914520952000_9.4.e014719.20","unstructured":"WHO . WHO Prequalifies a second malaria vaccine, a significant milestone in prevention of the disease. Geneva: World Health Organization; 2023.1."},{"key":"2025072914520952000_9.4.e014719.21","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1016\/S0140-6736(23)02511-4","article-title":"Safety and efficacy of malaria vaccine candidate R21\/matrix-M in African children: a multicentre, double-blind, randomised, phase 3 trial","volume":"403","author":"Datoo","year":"2024","journal-title":"Lancet"},{"key":"2025072914520952000_9.4.e014719.22","unstructured":"Tintou H , Ouedraogo JB , Hamaluba M , et al . Phase III: R21\/matrix-M. In American Society of Tropical Medicine and Hygiene (ASTMH) annual meeting; Chicago, USA, 2023"},{"key":"2025072914520952000_9.4.e014719.23","unstructured":"Market shaping Roadmaps- malaria vaccines. n.d. Available: https:\/\/www.gavi.org\/sites\/default\/files\/document\/Malaria-Roadmap-Public-Summary.pdf"},{"key":"2025072914520952000_9.4.e014719.24","doi-asserted-by":"crossref","unstructured":"Butler D . Promising malaria vaccine to be tested in first large field trial. Nature 2019. doi:10.1038\/d41586-019-01232-4","DOI":"10.1038\/d41586-019-01232-4"},{"key":"2025072914520952000_9.4.e014719.25","doi-asserted-by":"crossref","first-page":"1636","DOI":"10.1038\/s41591-021-01470-y","article-title":"Safety, Immunogenicity and efficacy of Pfspz vaccine against malaria in infants in Western Kenya: a double-blind, randomized, placebo-controlled phase 2 trial","volume":"27","author":"Oneko","year":"2021","journal-title":"Nat Med"},{"key":"2025072914520952000_9.4.e014719.26","unstructured":"WHO guidelines for malaria. 25 Nov 2022 edition. 2022."},{"key":"2025072914520952000_9.4.e014719.27","unstructured":"WHO . 2024. Cameroon kicks off malaria vaccine Rollout. World Health Organization; 1."},{"key":"2025072914520952000_9.4.e014719.28","unstructured":"WHO . Nearly 10 000 children vaccinated as malaria vaccine Rollout in Africa expands. Brazzaville: World Health Organization; 2024.1."},{"key":"2025072914520952000_9.4.e014719.29","unstructured":"Burkina Faso becomes 2ND African country to include malaria vaccine in immunization program. n.d. Available: https:\/\/www.africanews.com\/2024\/02\/05\/burkina-faso-becomes-2nd-african-country-to-include-malaria-vaccine-in-routine-immunizatio\/\/"},{"key":"2025072914520952000_9.4.e014719.30","doi-asserted-by":"crossref","DOI":"10.1186\/s12936-023-04657-5","article-title":"Implementation strategies for the introduction of the RTS,S\/As01 (RTS,S) malaria vaccine in countries with areas of highly seasonal transmission: workshop meeting report","volume":"22","author":"Merle","year":"2023","journal-title":"Malar J"},{"key":"2025072914520952000_9.4.e014719.31","doi-asserted-by":"crossref","DOI":"10.1136\/bmjgh-2023-011838","article-title":"Delivery strategies for malaria vaccination in areas with seasonal malaria transmission","volume":"8","author":"Grant","year":"2023","journal-title":"BMJ Glob Health"},{"key":"2025072914520952000_9.4.e014719.32","doi-asserted-by":"crossref","first-page":"1485","DOI":"10.1016\/S0140-6736(23)00902-9","article-title":"Gavi unveils malaria vaccine plans","volume":"401","author":"Zarocostas","year":"2023","journal-title":"Lancet"},{"key":"2025072914520952000_9.4.e014719.33","unstructured":"WHO . First malaria vaccine supply allocations may 2023. Geneva: World Health Organization; 2023.8."},{"key":"2025072914520952000_9.4.e014719.34","unstructured":"WHO . 18 million doses of first-ever malaria vaccine allocated to 12 African countries for 2023\u20132025. Gavi, WHO and UNICEF; 2023."},{"key":"2025072914520952000_9.4.e014719.35","unstructured":"Team W . WHO malaria vaccine global market study \u2013 September 2021. World Health Organization; 2021.5."},{"key":"2025072914520952000_9.4.e014719.36","doi-asserted-by":"crossref","DOI":"10.3389\/fpubh.2022.986776","article-title":"Ethical allocation of scarce vaccine doses: the priority-equality protocol","volume":"10","author":"Al\u00f3s-Ferrer","year":"2022","journal-title":"Front Public Health"},{"key":"2025072914520952000_9.4.e014719.37","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0159086","article-title":"How to fairly allocate scarce medical resources: ethical argumentation under scrutiny by health professionals and lay people","volume":"11","author":"Kr\u00fctli","year":"2016","journal-title":"PLoS One"},{"key":"2025072914520952000_9.4.e014719.38","doi-asserted-by":"crossref","DOI":"10.1186\/s12910-022-00806-8","article-title":"Ethical values and principles to guide the fair allocation of resources in response to a pandemic: a rapid systematic review","volume":"23","author":"O\u2019Sullivan","year":"2022","journal-title":"BMC Med Ethics"},{"key":"2025072914520952000_9.4.e014719.39","unstructured":"WHO . Framework for the allocation of limited malaria vaccine supply. Geneva: World Health Organization; 2022."},{"key":"2025072914520952000_9.4.e014719.40","doi-asserted-by":"crossref","first-page":"1892","DOI":"10.1016\/S0140-6736(23)00812-7","article-title":"The shared ethical framework to allocate scarce medical resources: a lesson from COVID-19","volume":"401","author":"Emanuel","year":"2023","journal-title":"Lancet"},{"key":"2025072914520952000_9.4.e014719.41","doi-asserted-by":"crossref","first-page":"850","DOI":"10.1136\/bmj.p850","article-title":"Ghana APPROVES Oxford\u2019s malaria vaccine for children aged 5 to 36 months","volume":"381","author":"Mahase","year":"2023","journal-title":"BMJ"},{"key":"2025072914520952000_9.4.e014719.42","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0209744","article-title":"Blencowe H: Current challenges and proposed solutions to the effective implementation of the RTS, S\/As01 malaria vaccine program in sub-Saharan Africa: a systematic review","volume":"13","author":"Dimala","year":"2018","journal-title":"PLoS One"},{"key":"2025072914520952000_9.4.e014719.43","doi-asserted-by":"crossref","DOI":"10.1186\/s12936-022-04168-9","article-title":"Challenges and lessons learned during the planning and early implementation of the RTS,S\/As01(E) malaria vaccine in three regions of Ghana: a qualitative study","volume":"21","author":"Grant","year":"2022","journal-title":"Malar J"},{"key":"2025072914520952000_9.4.e014719.44","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1093\/heapol\/czac077","article-title":"Barriers and Facilitators to nationwide implementation of the malaria vaccine in Ghana","volume":"38","author":"Adeshina","year":"2023","journal-title":"Health Policy Plan"},{"key":"2025072914520952000_9.4.e014719.45","doi-asserted-by":"publisher","DOI":"10.1080\/14760584.2019.1574224"},{"key":"2025072914520952000_9.4.e014719.46","doi-asserted-by":"crossref","DOI":"10.1186\/s12936-022-04378-1","article-title":"Predictors of malaria vaccine uptake among children 6-24 months in the kassena nankana municipality in the upper East region of Ghana","volume":"21","author":"Yeboah","year":"2022","journal-title":"Malar J"},{"key":"2025072914520952000_9.4.e014719.47","doi-asserted-by":"crossref","DOI":"10.1186\/s12889-023-15481-6","article-title":"Post introduction evaluation of the malaria vaccine implementation programme in Ghana, 2021","volume":"23","author":"Adjei","year":"2023","journal-title":"BMC Public Health"},{"key":"2025072914520952000_9.4.e014719.48","first-page":"7","article-title":"Assessing public awareness of the malaria vaccine in sub-Saharan Africa","volume":"7","author":"Aremu","year":"2022","journal-title":"Trop Med Infect Dis"},{"key":"2025072914520952000_9.4.e014719.49","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0278224","article-title":"Bako AT: a systematic review and meta-analysis of the prevalence of caregiver acceptance of malaria vaccine for under-five children in low-income and middle-income countries (Lmics)","volume":"17","author":"Sulaiman","year":"2022","journal-title":"PLoS One"},{"key":"2025072914520952000_9.4.e014719.50","doi-asserted-by":"crossref","DOI":"10.1186\/s12936-023-04536-z","article-title":"Perception and awareness towards malaria vaccine policy implementation in Nigeria by health policy actors","volume":"22","author":"Nnaji","year":"2023","journal-title":"Malar J"},{"key":"2025072914520952000_9.4.e014719.51","doi-asserted-by":"crossref","first-page":"e672","DOI":"10.1016\/S2214-109X(24)00013-5","article-title":"Integration of the RTS,S\/As01 malaria vaccine into the essential programme on Immunisation in Western Kenya: a qualitative longitudinal study from the health system perspective","volume":"12","author":"Hill","year":"2024","journal-title":"The Lancet Global Health"},{"key":"2025072914520952000_9.4.e014719.52","unstructured":"Report of the independent review committee to the GAVI alliance on the review of applications. GAVI; 2022.26."},{"key":"2025072914520952000_9.4.e014719.53","unstructured":"Hamel M . RTS,S\/As01 and MVIP update. In Virtual Malaria Policy Advisory Group (MPAG) Meeting; 2023"},{"key":"2025072914520952000_9.4.e014719.54","unstructured":"World Health O . WHO guidelines for malaria. 2022."},{"key":"2025072914520952000_9.4.e014719.55","doi-asserted-by":"publisher","DOI":"10.1016\/S1473-3099(22)00273-0"},{"key":"2025072914520952000_9.4.e014719.56","unstructured":"New financing agreement boost for malaria vaccine. Available: https:\/\/www.gavi.org\/news\/media-room\/new-financing-agreement-boost-malaria-vaccine?gclid=CjwKCAjwndCKBhAkEiwAgSDKQW7kiMf5iJOcb4NHuoNZPOLSTE97rJt3pQf7kRqUqRV0FsYiRZ75gRoCbhEQAvD_BwE"},{"key":"2025072914520952000_9.4.e014719.57","unstructured":"UNICEF signs deal to deliver new malaria vaccine in breakthrough for child survival. n.d. Available: https:\/\/www.unicef.org\/press-releases\/unicef-signs-deal-deliver-new-malaria-vaccine-breakthrough-child-survival"},{"key":"2025072914520952000_9.4.e014719.58","doi-asserted-by":"crossref","first-page":"1496","DOI":"10.1016\/j.vaccine.2023.01.043","article-title":"Cost of introducing and delivering RTS,S\/As01 malaria vaccine within the malaria vaccine implementation program","volume":"41","author":"Baral","year":"2023","journal-title":"Vaccine"},{"key":"2025072914520952000_9.4.e014719.59","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1136\/bmjgh-2022-011316","article-title":"Cost of introducing and delivering malaria vaccine (RTS,S\/As01(E)) in areas of seasonal malaria transmission, Mali and Burkina Faso","volume":"8","author":"Diawara","year":"2023","journal-title":"BMJ Glob Health"},{"key":"2025072914520952000_9.4.e014719.60","doi-asserted-by":"crossref","first-page":"e1782","DOI":"10.1016\/S2214-109X(22)00416-8","article-title":"Seasonal use case for the RTS,S\/As01 malaria vaccine: a mathematical modelling study","volume":"10","author":"Thompson","year":"2022","journal-title":"Lancet Glob Health"},{"key":"2025072914520952000_9.4.e014719.61","doi-asserted-by":"crossref","DOI":"10.1186\/s12936-017-1841-9","article-title":"Seasonal vaccination against malaria: a potential use for an imperfect malaria vaccine","volume":"16","author":"Greenwood","year":"2017","journal-title":"Malar J"},{"key":"2025072914520952000_9.4.e014719.62","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/S1473-3099(23)00368-7","article-title":"Seasonal vaccination with RTS,S\/As01(E) vaccine with or without seasonal malaria chemoprevention in children up to the age of 5 years in Burkina Faso and Mali: a double-blind, randomised, controlled, phase 3 trial","volume":"24","author":"Dicko","year":"2024","journal-title":"Lancet Infect Dis"}],"container-title":["BMJ Global Health"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/bmjgh-2023-014719","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,7,29]],"date-time":"2025-07-29T21:52:24Z","timestamp":1753825944000},"score":1,"resource":{"primary":{"URL":"https:\/\/gh.bmj.com\/lookup\/doi\/10.1136\/bmjgh-2023-014719"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,4]]},"references-count":62,"journal-issue":{"issue":"4","published-online":{"date-parts":[[2024,4,30]]},"published-print":{"date-parts":[[2024,4]]}},"alternative-id":["10.1136\/bmjgh-2023-014719"],"URL":"https:\/\/doi.org\/10.1136\/bmjgh-2023-014719","relation":{},"ISSN":["2059-7908"],"issn-type":[{"value":"2059-7908","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,4]]}}}